FAM
Fred Alger Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,949
| Closed | -$112K | – | 448 |
|
|
2023
Q3 | $112K | Sell |
2,949
-179,046
| -98% | -$6.81M | ﹤0.01% | 417 |
|
|
2023
Q2 | $16.6M | Sell |
181,995
-249
| -0.1% | -$22.7K | 0.08% | 169 |
|
|
2023
Q1 | $12M | Sell |
182,244
-24,019
| -12% | -$1.58M | 0.06% | 186 |
|
|
2022
Q4 | $10.7M | Buy |
206,263
+71,961
| +54% | +$3.72M | 0.06% | 208 |
|
|
2022
Q3 | $9.17M | Sell |
134,302
-2,197
| -2% | -$150K | 0.05% | 212 |
|
|
2022
Q2 | $6.17M | Buy |
136,499
+67,716
| +98% | +$3.06M | 0.03% | 244 |
|
|
2022
Q1 | $3.5M | Buy |
+68,783
| New | +$3.5M | 0.01% | 302 |
|
|
2021
Q1 | – | Sell |
-14,811
| Closed | -$847K | – | 478 |
|
|
2020
Q4 | $847K | Buy |
+14,811
| New | +$847K | ﹤0.01% | 382 |
|
|
2020
Q2 | – | Sell |
-5,000
| Closed | -$134K | – | 501 |
|
|
2020
Q1 | $134K | Sell |
5,000
-10,000
| -67% | -$268K | ﹤0.01% | 404 |
|
|
2019
Q4 | $459K | Sell |
15,000
-16,000
| -52% | -$490K | ﹤0.01% | 393 |
|
|
2019
Q3 | $747K | Buy |
31,000
+28,000
| +933% | +$675K | ﹤0.01% | 353 |
|
|
2019
Q2 | $76K | Buy |
+3,000
| New | +$76K | ﹤0.01% | 415 |
|